Atlas Trials

Non-Interventional Study of the Use of Alogliptin and Alogliptin Fixed-Dose Combinations With Pioglitazone and With Metformin in Standard Clinical Practice

Clinical trial NCT02989649 · TERMINATED

Trial details

NCT number
NCT02989649
Sponsor
Takeda
Status
TERMINATED
Study type
OBSERVATIONAL
Diabetes Mellitus, Type 2
Start date
2016-12-22
Primary completion
2018-01-26
Enrollment
593

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.